Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Seeking Alpha News (Sun, 24-Mar 8:01 AM ET)
Business Wire (Mon, 18-Mar 7:00 AM ET)
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Business Wire (Tue, 5-Mar 7:45 AM ET)
Oragenics Announces Closing of Public Offering
Business Wire (Fri, 1-Mar 4:04 PM ET)
Oragenics Announces Pricing of Public Offering
Business Wire (Tue, 27-Feb 9:25 PM ET)
Oragenics Announces Proposed Public Offering
Business Wire (Tue, 27-Feb 4:33 PM ET)
Oragenics, Inc. Announces Leadership Transition
Business Wire (Mon, 12-Feb 4:41 PM ET)
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
Business Wire (Wed, 7-Feb 8:00 AM ET)
Oragenics Announces Termination of At-The-Market Offering Program
Business Wire (Tue, 23-Jan 5:34 PM ET)
Oragenics Completes Acquisition of Odyssey Health's Neurological Assets
Business Wire (Tue, 2-Jan 7:30 AM ET)
Oragenics Inc is engaged in research and the development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its product (NT-CoV2-1) is an intranasal vaccine candidate to prevent coronavirus disease ("COVID-19") from the SARS-CoV-2 virus and variants thereof. Its focus on developing vaccines and novel antibiotics It is also developing a Terra CoV-2 immunization product candidate to combat the novel coronavirus.
Oragenics trades on the AMEX stock market under the symbol OGEN.
As of March 28, 2024, OGEN stock price climbed to $1.44 with 23,809 million shares trading.
OGEN has a beta of 0.97, meaning it tends to be less sensitive to market movements. OGEN has a correlation of 0.01 to the broad based SPY ETF.
OGEN has a market cap of $6.45 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, OGEN stock traded as high as $69.00 and as low as $1.26.
The top ETF exchange traded funds that OGEN belongs to (by Net Assets): VXF.
OGEN has underperformed the market in the last year with a price return of -45.0% while the SPY ETF gained +33.6%. OGEN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -73.8% and 0.0%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
OGEN support price is $1.34 and resistance is $1.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OGEN stock will trade within this expected range on the day.